Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
39S ribosomal protein L55, mitochondrial (MRPL55) is a nuclear-encoded component of the large 39S subunit of the mammalian mitochondrial ribosome (mitoribosome)[1][3][6][7]. This protein helps facilitate translation of mitochondrial-encoded proteins necessary for mitochondrial function and energy production. Mammalian mitoribosomes are distinctly different from their prokaryotic counterparts in protein:rRNA ratio and protein sequence composition[3][6]. MRPL55 is not used as a therapeutic target, nor is it a receptor, channel, or enzyme; its main biological role is structural, enabling mitochondrial translation[1][3][6][7].
Not applicable; no drugs known to target this protein directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 39S ribosomal protein L55, mitochondrial (MRPL55).